Download App

Log in to access Online Inquiry
Company Overview More
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
CEO: Yared, Nadim
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > CVRX CVRx Inc > Detailed Quotes

CVRX CVRx Inc

5.260+0.150+2.94%
Close 05/24 20:00 ET
5.26000.00%
Post Mkt Price 05/24 16:00 ET
High
5.330
Open
5.270
Turnover
450.69K
Low
5.020
Pre Close
5.110
Volume
86.94K
Market Cap
107.76M
P/E(TTM)
Loss
52wk High
29.000
Shares
20.49M
P/E(Static)
Loss
52wk Low
4.600
Float Cap
50.57M
Bid/Ask %
75.00%
Historical High
29.000
Shs Float
9.61M
Volume Ratio
1.35
Historical Low
4.600
Dividend TTM
--
Div Yield TTM
--
P/B
0.79
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.90%
Amplitude
6.07%
Avg Price
5.184
Lot Size
1
Float Cap
50.57M
Bid/Ask %
75.00%
Historical High
29.000
Shs Float
9.61M
Volume Ratio
1.35
Historical Low
4.600
Dividend TTM
--
P/B
0.79
Dividend LFY
--
Turnover Ratio
0.90%
Amplitude
6.07%
Avg Price
5.184
Lot Size
1
Price Forecast

No Data

News

Comment